Literature DB >> 26742952

Bioconversion of Iminodiacetonitrile to Iminodiacetic acid with whole cells of Lysinibacillus boronitolerans MTCC 107614 (IICT-akl252).

Hemalatha Muluka1,2, Gurrala Sheelu1, Y V D Nageshwar3.   

Abstract

Biotechnological potential of nitrilases are prompting significant interest in finding the novel microbes capable of hydrolyzing nitriles. In this view, we have screened about 450 bacterial strains for nitrilase production using bioconversion of iminodiacetonitrile (IDAN) to iminodiacetic acid (IDA) through hydrolysis and obtained six nitrilase-producing isolates. Among these six isolates, IICT-akl252 was promising which was identified as Lysinibacillus boronitolerans. This is the first report on L. boronitolerans for nitrilase activity. Optimization of various medium and reaction parameters for maximizing the nitrilase production using whole cells in shake flask was carried out for L. boronitolerans IICT-akl252. Sucrose (2 %) as a carbon source attained better nitrilase yield while IDAN appeared to be the preferable inducer (0.2 %). The maximum IDA formation was achieved with 100 mM IDAN and 150 mg/ml cells at 30 °C and pH 6.5. After optimization of the culture and reaction conditions, the activity of nitrilase was increased by 2.3-fold from 27.2 to 64.5 U. The enzyme was stable up to 1 h at 50 °C. The enzyme was able to hydrolyze aliphatic, aromatic and heterocyclic nitrile substrates.

Entities:  

Keywords:  Bio-transformation; Iminodiacetonitrile; Lysinibacillus boronitolerens MTCC 10761; Nitrilase; Substrate specificity

Mesh:

Substances:

Year:  2016        PMID: 26742952     DOI: 10.1007/s00449-015-1524-2

Source DB:  PubMed          Journal:  Bioprocess Biosyst Eng        ISSN: 1615-7591            Impact factor:   3.210


  1 in total

1.  Cloning, overexpression, and characterization of a thermostable nitrilase from an Antarctic Pyrococcus sp.

Authors:  Ma Ángeles Cabrera; Jenny M Blamey
Journal:  Extremophiles       Date:  2017-07-25       Impact factor: 2.395

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.